Navigation Links
New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
Date:5/9/2008

mpany, please visit http://www.PriCara.com.

Grunenthal

Grunenthal, a privately owned pharmaceutical company based in Aachen, Germany, discovered and started development of tapentadol. Grunenthal and J&JPRD have shared development responsibilities for tapentadol for acute and chronic pain conditions since the companies signed a licensing agreement for tapentadol in 2003.

Grunenthal licensed marketing rights to tapentadol to Ortho-McNeil-Janssen Pharmaceuticals, Inc. for the United States, Canada and Japan. Grunenthal maintains marketing rights in Europe and other parts of the world. A trade name for the product has not yet been determined.

[This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of the Company's Annual Report on Form 10-K for the fiscal year ended December 30, 2007. Copies of this Form 10-K, as well as subsequent filings, are available online at http://www.sec.gov, http://www.jnj.com or on request from Johnson & Johnson. Johns
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Larry J. Merlo , President ... will speak before the National Press Club in ... recent move to stop selling tobacco products and its leadership ... health. "Dramatic changes in our health care system ... government," Merlo has said. "CVS Health has a truly unique ...
(Date:9/19/2014)... , Sept. 19, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... collagenase-based products marketed as XIAFLEX ® in the U.S. ... BioSpecifics, President, Tom Wegman , will present a corporate ... the Biotech Industry Conference. The presentation will ... EDT at the Millennium Broadway Hotel in New ...
(Date:9/19/2014)... LOS ANGELES , Sept. 19, 2014  CytRx ... and development company specializing in oncology, today announced that ... will present at BioCentury,s 2014 NewsMakers in the Biotech ... p.m. Eastern Time. The conference will take place at ... City . A live and archived ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3
... , , , ... right brain fitness exercises can have a significant ... study recently published in BMC Health Services Research, a leading peer-reviewed health ... did just ten hours of special computerized brain exercises had better health ...
... PALO ALTO, Calif., Aug. 3 Telik, Inc. (Nasdaq: ... Phase 1 multicenter, dose escalation study of ezatiostat hydrochloride (TELINTRA, TLK199) ... a leading peer reviewed journal, Blood, 25 June 2009; ... separate Phase 1-2a study in MDS patients involving an intravenous formulation ...
Cached Medicine Technology:Study Shows Brain Fitness can Save Medicare Billions 2Study Shows Brain Fitness can Save Medicare Billions 3Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome 2
(Date:9/21/2014)... accommodate the ever-growing customer base, Angeldress.co.uk decided to implement ... the company has unveiled its 2014 vintage wedding ... gowns, Angeldress.co.uk wants to make sure that all customers ... Its high quality vintage wedding outfits are now available ... off. , Online shopping is becoming more and more ...
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... http://www.thegranuflolawsuit.com/ ) have been added over the past ... claims that allege serious cardiovascular injuries caused by ... A Case List updated on September 15th shows ... in the U.S. District Court, District of Massachusetts. ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 “Cluster headaches ... so intense and difficult to resolve,” said Steve Young ... can't think of a pain that is more intense.” ... suffers from cluster headaches, or migraines, that medical research ... the serotonin system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) ...
(Date:9/21/2014)... 2014 Developers and plugin specialist of ... a new transition plugin entitled Transpack Vol. 3 from ... quality transitions that will add a level of professionalism ... of Pixel Film Studios. “Blurring the line between professional ... changer.” , Transpack Vol. 3 returns with over 85 ...
(Date:9/21/2014)... C8 lawsuits move forward in the U.S. District ... 20 possible C8 lawsuits selected for bellwether trials ... & Schulte LLC. Court records show these six C8 ... filed that represent individuals who purportedly developed kidney cancer, ... being exposed to water contaminated by the C8 chemical ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4
... Retrieving about 15 eggs from a woman,s ovaries in a ... of achieving a live birth while avoiding complications from fertility ... than 400,000 IVF cycles in the United Kingdom between 1991 ... rates and the number of eggs retrieved in one cycle. ...
... and medical research information provided by traditional medianewspapers (77%), ... 66%), according to a new state poll commissioned by ... social media is not trustworthy for health and medical ... or other mobile device to find health information. ...
... how well someone will control their emotions? To predict ... stress? To accept critical feedback stoically? ... University, finds clues in what psychologists call "hot" and "cold" ... can control their emotions, and one factor that predicts it ...
... hopes are always placed in new cancer therapies. However, ... prolong the life of cancer patients, or even cure ... years, of testing. Researchers are therefore looking for proxy ... can reliably predict as quickly as possible whether the ...
... marital difficulties may have infants who are losing sleep, ... have a continuing impact on the children. Specifically, ... ninth months old was related to child sleep problems ... asleep, according to Anne Mannering, an Oregon State University ...
... selenium can reduce a person,s risk of cancer, a ... no protective effect against non-melanoma skin cancer or prostate ... selenium over a long period of time could have ... scanned the medical literature, looking for trials that studied ...
Cached Medicine News:Health News:Number of Eggs Retrieved Helps Predict IVF Success: Study 2Health News:Maryland poll: Traditional media and internet more trusted than social media for research news 2Health News:Maryland poll: Traditional media and internet more trusted than social media for research news 3Health News:When words get hot, mental multitaskers collect cool 2Health News:When words get hot, mental multitaskers collect cool 3Health News:How to recognize at an early stage whether a new cancer therapy prolongs life 2Health News:Marriage problems related to infants' sleep difficulties 2Health News:Taking additional selenium will not reduce cancer risk 2
... AquaFlow™ Collagen Glaucoma Drainage Device when ... procedure has been proven to significantly ... the complications often associated with penetrating ... medications. As a result, patient outcomes ...
... Control is a device ... a filter between the ... tubing that captures nuclear ... and efficiency of phaco ...
... is an innovative, stat analyzer that measures ... on-board co-oximetry and integrated data management "all ... include pH, PCO 2 , PO 2 ... sodium, potassium, chloride, ionized calcium, ionized magnesium, ...
... Bio-logic has demonstrated continuous innovations in computerized ... first Digital EEG system brings the latest ... VISION is the first Windows XP Pro ... all your EEG needs: epilepsy monitoring, routine ...
Medicine Products: